-
Archived | Autism Speaks: Diagnosis | Circa February 2005 #NotAnAutisticAlly #AutisticHistory
Diagnosis Presently, autism cannot be diagnosed by any one medical test. An accurate diagnosis can only be made after a trained professional has observed the communication, behavior, and developmental skills of the individual. Parental (and other caregivers’) input and developmental history can be very important in the diagnosis process. Many of the traits associated with […]
-
Archived | Autism test maker secures $9m | Circa June 2, 2010
Autism test maker secures $9m Globe Staff / June 2, 2010 SynapDx Corp., a new Waltham company that aims to develop tests for the early detection of autism, yesterday announced the completion of a $9 million round of financing. Investing were Bain Capital Ventures, General Catalyst Partners, and North Bridge Venture Partners. “Autism has a profound effect […]
-
Archived | Autism Genetic Resource Exchange (AGRE) Frequently Asked Questions Flyer For Parents | Circa 2007 #NotAnAutisticAlly
AUTISM GENETIC RESOURCE EXCHANGE FREQUENTLY ASKED QUESTIONS WHAT IS AGRE? The Autism Genetic Resource Exchange (AGRE) is a program that collects genetic, clinical and medical information from people with autism and their family members. Scientists from around the world who are studying autism can access this information from AGRE, which helps them find the causes […]
-
Archived | SynapDx Corporation’s CEO Stanley Lapidus Presents at Autism Speaks’ Inaugural Autism Investment Conference | Circa February 21, 2013 #NotAnAutisticAlly
FOR IMMEDIATE RELEASE SynapDx Corporation’s CEO Stanley Lapidus Presents at Inaugural Autism Investment Conference Discusses Diagnostic Issues at Event Hosted by Autism Speaks Lexington, MA – February 21, 2013 – SynapDx Corporation is joining a select group of autism-focused companies to present at the inaugural Autism Investment Conference, held today in New York, NY and […]